http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CA-1050019-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_56666880a5e2b7703e98a4f9b2d9daf6 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D267-20 |
| filingDate | 1975-10-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 1979-03-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_61f8f0a8979863ea854cfc61eeaba405 |
| publicationDate | 1979-03-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CA-1050019-A |
| titleOfInvention | 1-acyl-2-(8 chloro-10,11-dihydrodibenz (b,f) (1,4) oxazepine-10-carbonyl)hydrazines |
| abstract | ABSTRACT OF THE DISCLOSURE _ _ _ 1-Acyl-2-(8-chloro-10,11-dihydrodibenz[b,f]-[1,4]-oxazepine-10-carbonyl)hydrazines are described herein. They are useful pharmacological agents as evidenced by their anti-convulsant, topical anti-inflam-matory, and prostaglandin and 5-hydroxytryptamine antagonist activity. These compounds are prepared by the reaction of 8-chloro-10,11-dihydrodibenz[b,f][1,4]-oxazepine-10 carboxylic acid hydrazide with an appropriate acylating agent. Carboxyllc acid chlorides and carboxylic acid anhydrides are preferred acylating agents. |
| priorityDate | 1975-10-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 74.